Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
DaVita Inc
DVA | US
150.76
USD0.82
0.55%
DVA | US
About DaVita Inc
Sector
Healthcare
Industry
Medical Care Facilities
Earnings date
30/06/2024
As of date
06/03/2026
Close
150.76
Open
150.27
High
151.33
Low
147.47
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient hospital inpatient and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver Colorado.
View LessDVA | US
Risk
42.8
Sharpe
0.07
Luna's Score
40/100
Recommendation
Sell
Luna says (DVA | US)
What's Working
Largecap (10B - 200B USD)
What's not Working
Price Below SMA10D
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
28.5%1 month
42.8%3 months
53.3%6 months
42.0%Returns
Fundamental Ratios
PE
17.23
Fwd. PE
13.99
Price to book
21.22
Debt to equity
18.45
Debt to assets
0.69
Ent. to EBITDA
9.68
Ent. to rev.
1.97
PEG
1.49
Other Fundamentals
EBITDA
2.60B
MarketCap
12.65B
MarketCap(USD)
12.65B
Div. yield
-
Op. margin
16.20
Erngs. growth
30.90
Rev. growth
6.20
Ret. on equity
45.33
Short ratio
6.27
Short perc.
10.86
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
13.42
Range1M
23.52
Range3M
58.42
Volumes: Market Activity
Rel. volume
0.48
Price X volume
81.13M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 9.68 | - | Cheaper |
| Ent. to Revenue | 1.97 | - | Par |
| PE Ratio | 17.23 | 22.94 | Cheaper |
| Price to Book | 21.22 | 14.91 | Expensive |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 53.25 | - | Par |
| Debt to Equity | 18.45 | 5.15 | Expensive |
| Debt to Assets | 0.69 | 0.46 | Expensive |
| Market Cap | 12.65B | - | Market Leader |
